MOREPENLAB115.50

Morepen Laboratories Limited

· Pharma & Health
₹ CrorePeersIOLCPINNOVACAPFDCORCHPHARMASENORESSANOFIGUJTHEMRPGLIFEMcap ₹6,328 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation33.529.036.4
+ Impairment Loss / (Reversal)0.00.00.0
+ Finance Costs3.78.316.4
+ Unrealised FX (Gain) / Loss0.20.1-0.0
+ Other Non-cash Items0.00.0-0.8
Changes in Working Capital
+ Inventories-19.7-51.417.6
+ Trade Receivables — Current-61.70.2-50.1
+ Other Current Assets-56.2-130.9-92.6
+ Other Non-current Assets0.00.2-1.1
+ Trade Payables — Non-current0.00.0-24.7
+ Other Current Liabilities79.558.429.7
+ Provisions — Current-2.80.37.2
Cash from Operating Activities
Profit Before Tax (per I/S)135.4155.1119.9178.9
+ Total Adjustments (incl. Working Capital)-23.9-85.9-62.0
Cash from Operations (pre-tax)111.569.257.9
+ Income Taxes Paid38.137.225.3
Cash from Operating Activities73.432.132.6
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)71.4124.085.5
+ Acq of Intangible Assets10.090.275.0
+ Disp of Fixed Assets0.10.10.0
+ Acq of Investment Property1.383.70.0
+ Disp of Investment Property0.00.048.7
+ Acq of Other Long-term Assets0.723.643.3
+ Disp of Other Long-term Assets0.00.01.1
+ Disp of Subsidiaries / Businesses (net)0.00.030.6
Cash from Investing Activities-83.3-321.5-123.4
Cash from Financing Activities
+ Proceeds from Issue of Shares0.0190.70.0
+ Proceeds from Borrowings3.850.4131.8
+ Repayment of Borrowings0.00.016.4
+ Payment of Lease Liabilities0.0-25.75.7
+ Interest Paid3.78.316.4
+ Dividends Paid0.00.010.9
+ Other Inflows / (Outflows) — Financing5.141.415.0
Cash from Financing Activities5.2299.997.4
Net Changes in Cash (pre-FX)-4.710.46.6
Net Changes in Cash-4.710.46.6
Closing Cash16.9
Reference Items
EBITDA158.6174.1125.6184.0
EBITDA Margin %9.389.616.969.43
Free Cash Flow (CFO − Capex)-8.0-182.2-127.9-127.9
Free Cash Flow to Equity-140.1-29.0
Free Cash Flow per Basic Share-0.15-3.32-2.33-2.33
Cash Flow to Net Income0.760.270.34
Cash Paid for Taxes38.137.225.3
Cash Paid for Interest3.78.316.4
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.